CXCL8 and acute myeloid leukemia: In acute myeloid leukemia (AML), the activation of endothelial cells induces the secretion of interleukin-8 (IL-8), or via VEGF-a/VEGFR-2 signaling, leading to resistance to cytarabine (Ara-C) [92,93].